Overview
Infectious endocarditis (IE) remains a significant clinical challenge, characterized by the infection of the endocardium, typically involving heart valves. Contemporary epidemiological data indicate a notable rise in IE incidence, with estimates reaching 19.0 per 100,000 population in the United States and 21.3 per 100,000 in Western Europe by 2017, positioning it as the fourth most common systemic infection [PMID:32282401]. This increase is multifaceted, influenced by factors such as advancing age, congenital heart disease, and the growing prevalence of invasive medical procedures. Additionally, substance use disorders have emerged as a critical risk factor, contributing to a substantial rise in IE cases, particularly in urban settings, and often necessitating more aggressive interventions and leading to poorer long-term outcomes [PMID:32282401]. Understanding these trends is crucial for developing targeted prevention and management strategies.
Epidemiology
The incidence of infectious endocarditis (IE) has shown a concerning upward trend, reflecting broader changes in healthcare practices and patient demographics. By 2017, the incidence rates had climbed to 19.0 per 100,000 in the United States and 21.3 per 100,000 in Western Europe, underscoring its significance as a systemic infection [PMID:32282401]. This rise is particularly notable among populations with predisposing conditions such as age-related valve disease, congenital heart defects, and those requiring hemodialysis. The increasing frequency of invasive procedures, including central venous and arterial catheterizations, has been identified as a key driver of nosocomial IE cases [PMID:32282401]. These procedures not only introduce pathogens directly into the bloodstream but also prolong hospital stays, further elevating infection risks. Furthermore, the role of dental sources in precipitating IE cannot be overstated. Studies emphasize the importance of comprehensive dental screening before invasive cardiac surgeries, highlighting regional and national variations in risk profiles [PMID:35149804]. Effective pre-surgical dental assessments can significantly mitigate these risks, underscoring the need for integrated care pathways that address both cardiac and oral health.
Clinical Presentation
The clinical presentation of infectious endocarditis (IE) can be diverse, often mimicking other systemic illnesses, which complicates early diagnosis. A notable trend observed in recent years is the increased incidence of IE among individuals with substance use disorders, with cases rising from 6% to over 30% in large urban centers [PMID:32282401]. These patients frequently present with more severe manifestations, often requiring urgent surgical interventions and experiencing poorer long-term outcomes compared to those without substance use histories. Common clinical features include fever, weight loss, and signs of heart failure, alongside embolic phenomena such as stroke or peripheral emboli. Additionally, new or changing heart murmurs are critical indicators that should prompt further investigation. Regional audits and clinical guidelines highlight the importance of recognizing dental issues as potential triggers for IE, particularly in patients scheduled for invasive cardiac procedures [PMID:35149804]. Early identification and management of these dental risk factors are essential to prevent the progression to clinically significant IE.
Diagnosis
Diagnosing infectious endocarditis (IE) requires a multifaceted approach, integrating clinical suspicion with supportive laboratory and imaging findings. The Duke criteria remain a cornerstone for clinical diagnosis, encompassing major and minor criteria such as fever, vegetation on echocardiography, and positive blood cultures [PMID:32282401]. Advances in echocardiography, particularly transesophageal echocardiography (TEE), have significantly enhanced the detection of vegetations and valvular abnormalities, crucial for confirming the diagnosis. Blood cultures, while essential, may not always yield positive results, especially in the early stages of the disease or in cases involving fastidious organisms. Therefore, clinicians must maintain a high index of suspicion, especially in high-risk populations such as those with recent invasive procedures or known valvular abnormalities. The development of screening pro formas, which include detailed documentation of dental risk factors and pathology, has emerged as a practical tool to guide tailored preventative advice [PMID:35149804]. These tools aid in identifying patients at higher risk and facilitating early intervention to reduce the likelihood of IE development.
Management
The management of infectious endocarditis (IE) has evolved towards a multidisciplinary approach, emphasizing coordinated care to optimize outcomes. Antibiotic therapy remains the cornerstone of initial management, tailored based on the causative organism and its susceptibility patterns [PMID:32282401]. Early surgical intervention is crucial for patients with severe valvular dysfunction, uncontrolled sepsis, or recurrent embolic events. Formal multidisciplinary teams, comprising cardiologists, infectious disease specialists, and cardiac surgeons, have demonstrated improved in-hospital survival rates and reduced comorbidities through standardized antibiotic strategies and timely surgical interventions [PMID:32282401]. For instance, the University Hospital Bristol and Weston NHS Foundation Trust has implemented a comprehensive screening pro forma to assess dental health preoperatively, significantly reducing the risk of IE in patients undergoing invasive cardiac procedures [PMID:35149804]. This approach not only enhances diagnostic accuracy but also supports preemptive measures to mitigate infection risks. Post-operative care focuses on close monitoring for signs of recurrence and managing complications effectively, ensuring comprehensive patient recovery and follow-up.
Key Recommendations
References
1 Gibbons EF, Huang G, Aldea G, Koomalsingh K, Klein JW, Dhanireddy S et al.. A Multidisciplinary Pathway for the Diagnosis and Treatment of Infectious Endocarditis. Critical pathways in cardiology 2020. link 2 Allen G, Brooke A. Devising a pro forma for dental screening of patients before invasive cardiac surgery. British dental journal 2022. link